BIOSYNEX INH. EO-10
Healthcare · EUR · F
Price
€1.017
Cap
€14.93M
Earnings
—
30d Trend
+22.5%
126% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 43×Macro 0.99 (−1%)=43
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
6-9 month momentum thesis — strong trend with confirmation
BRAIN47'S ASSESSMENT
I rate BIOSYNEX INH. EO-10 at 43/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is technical at 56/100. I classify this as a speculative position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
+32.5%
3 MONTHS
+13.7%
12 MONTHS
-18.1%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
6-9 month momentum thesis — strong trend with confirmation. Technical (56) and Fundamentals (50) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 126%. I classify this as a speculative position — elevated volatility at 126% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.